Correlation Between SAB Biotherapeutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on SAB Biotherapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Pasithea Therapeutics.
Diversification Opportunities for SAB Biotherapeutics and Pasithea Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between SAB and Pasithea is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Pasithea Therapeutics
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 1.66 times more return on investment than Pasithea Therapeutics. However, SAB Biotherapeutics is 1.66 times more volatile than Pasithea Therapeutics Corp. It trades about 0.05 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.05 per unit of risk. If you would invest 292.00 in SAB Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 5.00 from holding SAB Biotherapeutics or generate 1.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 50.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| SAB Biotherapeutics |
| Pasithea Therapeutics |
SAB Biotherapeutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Pasithea Therapeutics
The main advantage of trading using opposite SAB Biotherapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Scpharmaceuticals | Pasithea Therapeutics vs. Milestone Pharmaceuticals | Pasithea Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |